NEW YORK (TheStreet) -- Shares of St. Jude Medical (STJ are down by 0.24% to $58.51 in mid-morning trading on Tuesday, as the company prepares to release its latest quarterly financial report.

Medical device maker St. Jude Medical will release its first-quarter earnings before the market open on Wednesday morning.

Analysts are expecting that the company will post a year over year decline in its earnings per share results, but a 6.6% rise in revenue.

A survey of analysts taken by Thomson Reuters shows that the company has been forecast to report earnings of 88 cents per share on revenue of $1.43 billion for the three month period ended in March.

St. Jude Medical reported non-GAAP earnings of 93 cents per share on revenue of $1.35 billion for the 2015 first quarter.

St. Jude Medical is a St. Paul Minn.-based developer, manufacturer and distributor of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders.

Separately, TheStreet Ratings has set a "hold" rating and a score of C+ on St. Jude Medical stock. The primary factors that have impacted the rating are mixed - some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks.

The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels and expanding profit margins. However, as a counter to these strengths, TheStreet Ratings also finds weaknesses including deteriorating net income, generally higher debt management risk and weak operating cash flow.

TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.

You can view the full analysis from the report here: STJ